Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 389

1.

Chronic Kidney Disease: Exploring Value-Based Healthcare as a Potential Viable Solution.

Busink E, Canaud B, Schröder-Bäck P, Paulus ATG, Evers SMAA, Apel C, Bowry SK, Stopper A.

Blood Purif. 2019 Feb 1;47(1-3):156-165. doi: 10.1159/000496681. [Epub ahead of print] Review.

2.

Clinical outcomes of hemodialysis patients in a public-private partnership care framework in Italy: a retrospective cohort study.

Pedrini LA, Winter AC, Cerino F, Zawada AM, Garbelli M, Feuersenger A, Feliciani A, Ruggiero P, Civardi S, Amato C, Canaud B, Stuard S, Karch A, Gauly A.

BMC Nephrol. 2019 Feb 1;20(1):35. doi: 10.1186/s12882-019-1224-2.

3.

Sodium and water handling during hemodialysis: new pathophysiologic insights and management approaches for improving outcomes in end-stage kidney disease.

Canaud B, Kooman J, Selby NM, Taal M, Francis S, Kopperschmidt P, Maierhofer A, Kotanko P, Titze J.

Kidney Int. 2019 Feb;95(2):296-309. doi: 10.1016/j.kint.2018.09.024. Review.

PMID:
30665570
4.

Increased Mortality Associated with Higher Pre-Dialysis Serum Sodium Variability: Results of the International MONitoring Dialysis Outcome Initiative.

Ye X, Kooman JP, van der Sande FM, Canaud B, Stuard S, Etter M, Xu X, Marelli C, Guinsburg A, Power A, Usvyat LA, Wang Y, Kotanko P, Raimann JG; for the MONDO Initiative.

Am J Nephrol. 2019;49(1):1-10. doi: 10.1159/000495354. Epub 2018 Dec 13.

PMID:
30544113
5.

A Cross-Sectional Study of Growth and Metabolic Bone Disease in a Pediatric Global Cohort Undergoing Chronic Hemodialysis.

Hussein R, Alvarez-Elías AC, Topping A, Raimann JG, Filler G, Yousif D, Kotanko P, Usvyat LA, Medeiros M, Pecoits-Filho R, Canaud B, Stuard S, Xiaoqi X, Etter M, Díaz-González de Ferris ME; MONDO Consortium.

J Pediatr. 2018 Nov;202:171-178.e3. doi: 10.1016/j.jpeds.2018.07.033. Epub 2018 Sep 26.

PMID:
30268401
6.

Zero Diffusive Sodium Balance in Hemodialysis Provided by an Algorithm-Based Electrolyte Balancing Controller: A Proof of Principle Clinical Study.

Kuhlmann U, Maierhofer A, Canaud B, Hoyer J, Gross M.

Artif Organs. 2018 Sep 27. doi: 10.1111/aor.13328. [Epub ahead of print]

PMID:
30260035
7.

Detecting high-risk chronic kidney disease-mineral bone disorder phenotypes among patients on dialysis: a historical cohort study.

Neri L, Kreuzberg U, Bellocchio F, Brancaccio D, Barbieri C, Canaud B, Stuard S, Ketteler M.

Nephrol Dial Transplant. 2018 Aug 27. doi: 10.1093/ndt/gfy273. [Epub ahead of print]

PMID:
30165528
8.

Interactions Between Malnutrition, Inflammation, and Fluid Overload and Their Associations With Survival in Prevalent Hemodialysis Patients.

Dekker MJE, Konings C, Canaud B, van der Sande FM, Stuard S, Raimann JG, Öztürk E, Usvyat L, Kotanko P, Kooman JP.

J Ren Nutr. 2018 Nov;28(6):435-444. doi: 10.1053/j.jrn.2018.06.005. Epub 2018 Aug 23.

PMID:
30146272
9.

Lipid levels are inversely associated with infectious and all-cause mortality: international MONDO study results.

Kaysen GA, Ye X, Raimann JG, Wang Y, Topping A, Usvyat LA, Stuard S, Canaud B, van der Sande FM, Kooman JP, Kotanko P; Monitoring Dialysis Outcomes (MONDO) Initiative.

J Lipid Res. 2018 Aug;59(8):1519-1528. doi: 10.1194/jlr.P084277. Epub 2018 Jun 12.

10.

CVD diamond detector with interdigitated electrode pattern for time-of-flight energy-loss measurements of low-energy ion bunches.

Cayzac W, Pomorski M, Blažević A, Canaud B, Deslandes D, Fariaut J, Gontier D, Lescoute E, Marmouget JG, Occelli F, Oudot G, Reverdin C, Sauvestre JE, Sollier A, Soullié G, Varignon C, Villette B.

Rev Sci Instrum. 2018 May;89(5):053301. doi: 10.1063/1.5019879.

PMID:
29864825
11.

Proton Pump Inhibitor Usage and the Risk of Mortality in Hemodialysis Patients.

de Francisco ALM, Varas J, Ramos R, Merello JI, Canaud B, Stuard S, Pascual J, Aljama P; Optimizing Results in Dialysis (ORD) group.

Kidney Int Rep. 2017 Nov 10;3(2):374-384. doi: 10.1016/j.ekir.2017.11.001. eCollection 2018 Mar.

12.

Pre-dialysis fluid status, pre-dialysis systolic blood pressure and outcome in prevalent haemodialysis patients: results of an international cohort study on behalf of the MONDO initiative.

Dekker M, Konings C, Canaud B, Carioni P, Guinsburg A, Madero M, van der Net J, Raimann J, van der Sande F, Stuard S, Usvyat L, Wang Y, Xu X, Kotanko P, Kooman J.

Nephrol Dial Transplant. 2018 Nov 1;33(11):2027-2034. doi: 10.1093/ndt/gfy095.

PMID:
29718469
13.

Greater fluid overload and lower interdialytic weight gain are independently associated with mortality in a large international hemodialysis population.

Hecking M, Moissl U, Genser B, Rayner H, Dasgupta I, Stuard S, Stopper A, Chazot C, Maddux FW, Canaud B, Port FK, Zoccali C, Wabel P.

Nephrol Dial Transplant. 2018 Oct 1;33(10):1832-1842. doi: 10.1093/ndt/gfy083.

14.

Is There Not Sufficient Evidence to Show That Haemodiafiltration Is Superior to Conventional Haemodialysis in Treating End-Stage Kidney Disease Patients?

Canaud B, Busink E, Apel C, Bowry SK.

Blood Purif. 2018;46(1):7-11. doi: 10.1159/000487918. Epub 2018 Apr 12. No abstract available.

15.

Health-related quality of life in end-stage renal disease patients: the effects of starting dialysis in the first year after the transition period.

Broers NJH, Martens RJH, Canaud B, Cornelis T, Dejagere T, Diederen NMP, Hermans MMH, Konings CJAM, Stifft F, Wirtz JJJM, Leunissen KML, van der Sande FM, Kooman JP.

Int Urol Nephrol. 2018 Jun;50(6):1131-1142. doi: 10.1007/s11255-018-1845-6. Epub 2018 Mar 26.

16.

Regulatory Considerations for Hemodiafiltration in the United States.

Ward RA, Vienken J, Silverstein DM, Ash S, Canaud B; Kidney Health Initiative HDF Workgroup.

Clin J Am Soc Nephrol. 2018 Sep 7;13(9):1444-1449. doi: 10.2215/CJN.12641117. Epub 2018 Mar 6.

PMID:
29511058
17.

Hemodiafiltration to Address Unmet Medical Needs ESKD Patients.

Canaud B, Vienken J, Ash S, Ward RA; Kidney Health Initiative HDF Workgroup.

Clin J Am Soc Nephrol. 2018 Sep 7;13(9):1435-1443. doi: 10.2215/CJN.12631117. Epub 2018 Mar 6.

PMID:
29511057
18.

Association between Heights of Dialysis Patients and Outcomes: Results from a Retrospective Cohort Study of the International MONitoring Dialysis Outcomes (MONDO) Database Initiative.

Patel S, Topping A, Ye X, Zhang H, Canaud B, Carioni P, Marelli C, Guinsburg A, Power A, Duncan N, Kooman J, van der Sande F, Usvyat LA, Wang Y, Xu X, Kotanko P, Raimann JG; the MONDO Initiative.

Blood Purif. 2018;45(1-3):245-253. doi: 10.1159/000485162. Epub 2018 Jan 26.

19.
20.

[Aluminic intoxication in chronic hemodialysis. A diagnosis rarely evoked nowadays. Clinical case and review of the literature].

Seidowsky A, Dupuis E, Drueke T, Dard S, Massy ZA, Canaud B.

Nephrol Ther. 2018 Feb;14(1):35-41. doi: 10.1016/j.nephro.2017.04.002. Epub 2017 Nov 23. Review. French.

PMID:
29174672
21.

Increased mortality in haemodialysis patients administered high doses of erythropoiesis-stimulating agents: a propensity score-matched analysis.

Pérez-García R, Varas J, Cives A, Martín-Malo A, Aljama P, Ramos R, Pascual J, Stuard S, Canaud B, Merello JI; ORD group.

Nephrol Dial Transplant. 2018 Jan 1;33(1):187. doi: 10.1093/ndt/gfx315. No abstract available.

PMID:
29077898
22.

Hemodiafiltration Reduces All-Cause and Cardiovascular Mortality in Incident Hemodialysis Patients: A Propensity-Matched Cohort Study.

Maduell F, Varas J, Ramos R, Martin-Malo A, Pérez-Garcia R, Berdud I, Moreso F, Canaud B, Stuard S, Gauly A, Aljama P, Merello JI.

Am J Nephrol. 2017;46(4):288-297. doi: 10.1159/000481669. Epub 2017 Oct 17.

PMID:
29041011
23.

Increased mortality in haemodialysis patients administered high doses of erythropoiesis-stimulating agents: a propensity score-matched analysis.

Pérez-García R, Varas J, Cives A, Martín-Malo A, Aljama P, Ramos R, Pascual J, Stuard S, Canaud B, Merello JI; ORD group.

Nephrol Dial Transplant. 2018 Apr 1;33(4):690-699. doi: 10.1093/ndt/gfx269.

PMID:
29036505
24.

Relationships between iron dose, hospitalizations and mortality in incident haemodialysis patients: a propensity-score matched approach.

Varas J, Ramos R, Aljama P, Pérez-García R, Moreso F, Pinedo M, Ignacio Merello J, Stuard S, Canaud B, Martín-Malo A; ORD Group.

Nephrol Dial Transplant. 2018 Jan 1;33(1):160-170. doi: 10.1093/ndt/gfx209.

PMID:
28992120
25.

Warfarin in CKD patients with atrial fibrillation.

Brancaccio D, Neri L, Bellocchio F, Barbieri C, Amato C, Mari F, Canaud B, Stuard S.

Kidney Int. 2017 Sep;92(3):766-767. doi: 10.1016/j.kint.2017.06.005. No abstract available.

PMID:
28807266
26.

Physical Activity in End-Stage Renal Disease Patients: The Effects of Starting Dialysis in the First 6 Months after the Transition Period.

Broers NJH, Martens RJH, Cornelis T, van der Sande FM, Diederen NMP, Hermans MMH, Wirtz JJJM, Stifft F, Konings CJAM, Dejagere T, Canaud B, Wabel P, Leunissen KML, Kooman JP.

Nephron. 2017;137(1):47-56. doi: 10.1159/000476072. Epub 2017 Jun 8.

27.

Dialysis Access as an Area of Improvement in Elderly Incident Hemodialysis Patients: Results from a Cohort Study from the International Monitoring Dialysis Outcomes Initiative.

Raimann JG, Barth C, Usvyat LA, Preciado P, Canaud B, Etter M, Xu X, Guinsburg A, Marelli C, Duncan N, Power A, van der Sande FM, Kooman JP, Thijssen S, Wang Y, Kotanko P; Monitoring Dialysis Outcomes (MONDO) Initiative.

Am J Nephrol. 2017;45(6):486-496. doi: 10.1159/000476003. Epub 2017 May 17.

PMID:
28514783
28.

[Online hemodiafiltration: Practical aspects, safety and efficacy].

Canaud B, Chénine L, Leray-Moraguès H, Patrier L, Rodriguez A, Gontier-Picard A, Moréna M.

Nephrol Ther. 2017 May;13(3):189-201. doi: 10.1016/j.nephro.2017.02.007. Epub 2017 May 5. French.

PMID:
28483384
29.

Cardiovascular outcome trials in patients with chronic kidney disease: challenges associated with selection of patients and endpoints.

Rossignol P, Agarwal R, Canaud B, Charney A, Chatellier G, Craig JC, Cushman WC, Gansevoort RT, Fellström B, Garza D, Guzman N, Holtkamp FA, London GM, Massy ZA, Mebazaa A, Mol PGM, Pfeffer MA, Rosenberg Y, Ruilope LM, Seltzer J, Shah AM, Shah S, Singh B, Stefánsson BV, Stockbridge N, Stough WG, Thygesen K, Walsh M, Wanner C, Warnock DG, Wilcox CS, Wittes J, Pitt B, Thompson A, Zannad F.

Eur Heart J. 2017 Apr 18. doi: 10.1093/eurheartj/ehx209. [Epub ahead of print]

PMID:
28431138
30.

Plasma PCSK9 concentrations during the course of nondiabetic chronic kidney disease: Relationship with glomerular filtration rate and lipid metabolism.

Morena M, Le May C, Chenine L, Arnaud L, Dupuy AM, Pichelin M, Leray-Moragues H, Chalabi L, Canaud B, Cristol JP, Cariou B.

J Clin Lipidol. 2017 Jan - Feb;11(1):87-93. doi: 10.1016/j.jacl.2016.10.005. Epub 2016 Oct 15.

PMID:
28391915
31.

The importance of considering competing treatment affecting prognosis in the evaluation of therapy in trials: the example of renal transplantation in hemodialysis trials.

Hazelbag CM, Peters SAE, Blankestijn PJ, Bots ML, Canaud B, Davenport A, Grooteman MPC, Kircelli F, Locatelli F, Maduell F, Morena M, Nubé MJ, Ok E, Torres F, Hoes AW, Groenwold RHH; HDF Pooling Project investigators.

Nephrol Dial Transplant. 2017 Apr 1;32(suppl_2):ii31-ii39. doi: 10.1093/ndt/gfw458.

PMID:
28339826
32.

Treatment tolerance and patient-reported outcomes favor online hemodiafiltration compared to high-flux hemodialysis in the elderly.

Morena M, Jaussent A, Chalabi L, Leray-Moragues H, Chenine L, Debure A, Thibaudin D, Azzouz L, Patrier L, Maurice F, Nicoud P, Durand C, Seigneuric B, Dupuy AM, Picot MC, Cristol JP, Canaud B; FRENCHIE Study Investigators.

Kidney Int. 2017 Jun;91(6):1495-1509. doi: 10.1016/j.kint.2017.01.013. Epub 2017 Mar 18.

PMID:
28318624
33.

Impact of fluid status and inflammation and their interaction on survival: a study in an international hemodialysis patient cohort.

Dekker MJ, Marcelli D, Canaud BJ, Carioni P, Wang Y, Grassmann A, Konings CJ, Kotanko P, Leunissen KM, Levin NW, van der Sande FM, Ye X, Maheshwari V, Usvyat LA, Kooman JP; MONDO Initiative.

Kidney Int. 2017 May;91(5):1214-1223. doi: 10.1016/j.kint.2016.12.008. Epub 2017 Feb 13.

34.

Intradialytic Cardiac Magnetic Resonance Imaging to Assess Cardiovascular Responses in a Short-Term Trial of Hemodiafiltration and Hemodialysis.

Buchanan C, Mohammed A, Cox E, Köhler K, Canaud B, Taal MW, Selby NM, Francis S, McIntyre CW.

J Am Soc Nephrol. 2017 Apr;28(4):1269-1277. doi: 10.1681/ASN.2016060686. Epub 2016 Nov 10.

35.

Mortality reduction by post-dilution online-haemodiafiltration: a cause-specific analysis.

Nubé MJ, Peters SAE, Blankestijn PJ, Canaud B, Davenport A, Grooteman MPC, Asci G, Locatelli F, Maduell F, Morena M, Ok E, Torres F, Bots ML; HDF Pooling Project investigators.

Nephrol Dial Transplant. 2017 Mar 1;32(3):548-555. doi: 10.1093/ndt/gfw381.

PMID:
28025382
36.

Initiation of Renal-Replacement Therapy in the Intensive Care Unit.

Canaud B, Cohen EP.

N Engl J Med. 2016 Nov 10;375(19):1901. doi: 10.1056/NEJMc1610500. No abstract available.

PMID:
27959655
37.

Clinical Performance Assessment of CorDiax Filters in Hemodialysis and Hemodiafiltration.

Potier J, Bowry S, Canaud B.

Contrib Nephrol. 2017;189:237-245. Epub 2016 Dec 12.

PMID:
27951574
38.

What Is the Optimal Target Convective Volume in On-Line Hemodiafiltration Therapy?

Canaud B, Koehler K, Bowry S, Stuard S.

Contrib Nephrol. 2017;189:9-16. Epub 2016 Dec 12. Review.

PMID:
27951545
39.

Improving outcomes of dialysis patients by population health management-the Global Chief Medical Officer Initiative.

Canaud B, Hegbrant J, Nissenson AR, Barth C, Maddux F, Etter M, Krishnan M.

Lancet. 2016 Oct 22;388(10055):1966-1967. doi: 10.1016/S0140-6736(16)31894-3. No abstract available.

PMID:
27789006
40.

Patients' Characteristics Affect the Survival Benefit of Warfarin Treatment for Hemodialysis Patients with Atrial Fibrillation. A Historical Cohort Study.

Brancaccio D, Neri L, Bellocchio F, Barbieri C, Amato C, Mari F, Canaud B, Stuard S.

Am J Nephrol. 2016;44(4):258-267. Epub 2016 Sep 7.

41.

Cost-effectiveness analysis of online hemodiafiltration versus high-flux hemodialysis.

Ramponi F, Ronco C, Mason G, Rettore E, Marcelli D, Martino F, Neri M, Martin-Malo A, Canaud B, Locatelli F.

Clinicoecon Outcomes Res. 2016 Sep 22;8:531-540. eCollection 2016.

42.

Reconciling and Closing the Loop Between Evidence-Based and Practice-Based Medicine: The Case for Hemodiafiltration.

Canaud B, Blankestijn PJ, Davenport A, Bots ML.

Am J Kidney Dis. 2016 Aug;68(2):176-179. doi: 10.1053/j.ajkd.2016.05.006. No abstract available.

PMID:
27477357
43.

An international observational study suggests that artificial intelligence for clinical decision support optimizes anemia management in hemodialysis patients.

Barbieri C, Molina M, Ponce P, Tothova M, Cattinelli I, Ion Titapiccolo J, Mari F, Amato C, Leipold F, Wehmeyer W, Stuard S, Stopper A, Canaud B.

Kidney Int. 2016 Aug;90(2):422-429. doi: 10.1016/j.kint.2016.03.036. Epub 2016 Jun 2.

PMID:
27262365
44.

Dynamics of the erythropoiesis stimulating agent resistance index in incident hemodiafiltration and high-flux hemodialysis patients.

Marcelli D, Bayh I, Merello JI, Ponce P, Heaton A, Kircelli F, Chazot C, Di Benedetto A, Marelli C, Ladanyi E, Kroczak M, Stuard S, Grassmann A, Scatizzi L, Brand K, Canaud B.

Kidney Int. 2016 Jul;90(1):192-202. doi: 10.1016/j.kint.2016.03.009. Epub 2016 May 10.

PMID:
27178833
45.

Unraveling the relationship between mortality, hyponatremia, inflammation and malnutrition in hemodialysis patients: results from the international MONDO initiative.

Dekker MJ, Marcelli D, Canaud B, Konings CJ, Leunissen KM, Levin NW, Carioni P, Maheshwari V, Raimann JG, van der Sande FM, Usvyat LA, Kotanko P, Kooman JP.

Eur J Clin Nutr. 2016 Jul;70(7):779-84. doi: 10.1038/ejcn.2016.49. Epub 2016 Apr 20.

PMID:
27094625
46.

Atrial fibrillation in dialysis patients: time to abandon warfarin?

Brancaccio D, Neri L, Bellocchio F, Barbieri C, Amato C, Mari F, Canaud B, Stuard S.

Int J Artif Organs. 2016 May 16;39(3):99-105. doi: 10.5301/ijao.5000487. Epub 2016 Apr 9. Review.

PMID:
27079417
47.

High-Flux Hemodialysis and High-Volume Hemodiafiltration Improve Serum Calcification Propensity.

Dekker M, Pasch A, van der Sande F, Konings C, Bachtler M, Dionisi M, Meier M, Kooman J, Canaud B.

PLoS One. 2016 Apr 11;11(4):e0151508. doi: 10.1371/journal.pone.0151508. eCollection 2016. Erratum in: PLoS One. 2016;11(6):e0156923.

48.

Performance of a Predictive Model for Long-Term Hemoglobin Response to Darbepoetin and Iron Administration in a Large Cohort of Hemodialysis Patients.

Barbieri C, Bolzoni E, Mari F, Cattinelli I, Bellocchio F, Martin JD, Amato C, Stopper A, Gatti E, Macdougall IC, Stuard S, Canaud B.

PLoS One. 2016 Mar 3;11(3):e0148938. doi: 10.1371/journal.pone.0148938. eCollection 2016.

49.

Longitudinal Changes in Body Composition in Patients After Initiation of Hemodialysis Therapy: Results From an International Cohort.

Marcelli D, Brand K, Ponce P, Milkowski A, Marelli C, Ok E, Merello Godino JI, Gurevich K, Jirka T, Rosenberger J, Di Benedetto A, Ladányi E, Grassmann A, Scatizzi L, Bayh I, Kooman J, Canaud B.

J Ren Nutr. 2016 Mar;26(2):72-80. doi: 10.1053/j.jrn.2015.10.001. Epub 2015 Nov 28.

50.

Haemodiafiltration and mortality in end-stage kidney disease patients: a pooled individual participant data analysis from four randomized controlled trials.

Peters SA, Bots ML, Canaud B, Davenport A, Grooteman MP, Kircelli F, Locatelli F, Maduell F, Morena M, Nubé MJ, Ok E, Torres F, Woodward M, Blankestijn PJ; HDF Pooling Project Investigators.

Nephrol Dial Transplant. 2016 Jun;31(6):978-84. doi: 10.1093/ndt/gfv349. Epub 2015 Oct 22.

PMID:
26492924

Supplemental Content

Loading ...
Support Center